Approximately 1 in 6 patients experience antidepressant withdrawal symptoms, systematic review finds

FHS
June 13, 2024
2:18 pm

Researchers performed a meta-analysis to determine the prevalence of antidepressant discontinuation symptoms.

Novo Nordisk’s once-weekly insulin will face FDA adcomm in May, following review extension

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will meet on May 24 to discuss Novo Nordisk’s application for a once-weekly insulin. The drug candidate,

April 30, 2024

What do new weight loss drugs mean for the future of bariatric surgery?

Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery. For obesity,

August 28, 2023

Enzymatic RNA synthesis paves the way for sustainable therapeutics

While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.